NKGen Biotech Files 8-K Report
| Field | Detail |
|---|---|
| Company | Nkgen Biotech, Inc. |
| Form Type | 8-K |
| Filed Date | Jun 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-filing
TL;DR
NKGen Biotech filed an 8-K, likely routine updates. Check for details.
AI Summary
On June 18, 2025, NKGen Biotech, Inc. filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits, with no specific material event detailed in the provided text. The company, formerly Graf Acquisition Corp. IV, is incorporated in Delaware and based in Santa Ana, California.
Why It Matters
This filing indicates routine corporate reporting, potentially including updates on financial status or other operational matters that could influence investor decisions.
Risk Assessment
Risk Level: low — The provided text is a standard 8-K filing header and does not contain information about specific material events, risks, or financial performance.
Key Players & Entities
- NKGen Biotech, Inc. (company) — Registrant
- Graf Acquisition Corp. IV (company) — Former company name
- June 18, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Santa Ana, CA (location) — Company address
FAQ
What is the primary purpose of this 8-K filing for NKGen Biotech, Inc.?
The filing is a Current Report on Form 8-K, indicating 'Other Events' and 'Financial Statements and Exhibits' as the items of disclosure.
When was the earliest event reported in this filing?
The earliest event reported is dated June 18, 2025.
What was NKGen Biotech, Inc.'s former company name?
NKGen Biotech, Inc.'s former company name was Graf Acquisition Corp. IV.
In which state is NKGen Biotech, Inc. incorporated?
NKGen Biotech, Inc. is incorporated in Delaware.
What is the business address of NKGen Biotech, Inc.?
The business address is 3001 Daimler Street, Santa Ana, CA, 92705.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 20, 2025 regarding NKGen Biotech, Inc..